Search Results - Igor Latorzeff

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Enhancing the referral process for surgical management of spinal metastases: insights from a 12-year, bi-institutional study of 533 patients by Bertrand Debono, Alexis Perez, Guillaume Lonjon, Olivier Hamel, Jean-Baptiste Dandine, Martin Dupuy, Guillaume Dutertre, Cécile Braticevic, Igor Latorzeff, Aymeric Amelot

    Published in Frontiers in Oncology (2024-01-01)
    Get full text
    Article


  2. 2

    Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept by Florent Vilotte, Mickael Antoine, Maxime Bobin, Igor Latorzeff, Stéphane Supiot, Pierre Richaud, Laurence Thomas, Nicolas Leduc, Stephane Guérif, Jone Iriondo-Alberdi, Renaud de Crevoisier, Paul Sargos

    Published in Frontiers in Oncology (2017-03-01)
    Get full text
    Article


  3. 3

    Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer by Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier, Nathalie Mesgouez-Nebout, Philippe Giraud, Didier Peiffert, Bruno Chauvet, Philippe Dudouet, Naji Salem, Georges Noël, Jonathan Khalifa, Igor Latorzeff, Catherine Guérin-Charbonnel, Stéphane Supiot

    Get full text
    Article


  4. 4

    Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer by Martin Boegemann, Mostefa Bennamoun, Louis Marie Dourthe, Juan Antonio Encarnacion, Axel Hegele, Eva Hellmis, Igor Latorzeff, Wolfgang Leicht, Julián Oñate-Celdrán, Antonio Rosino-Sánchez, Krystelle Hanna, Joana Lencart, Martin Lukac, Claudio A. Schioppa, Suzy Van Sanden, Gero Kramer

    Published in BMC Cancer (2025-07-01)
    Get full text
    Article


  5. 5

    Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study... by Maximilien Rogé, Yoann Pointreau, Paul Sargos, Emmanuel Meyer, Ulrike Schick, Ali Hasbini, Emmanuel Rio, Guillaume Bera, Amandine Ruffier, Magali Quivrin, Mathieu Chasseray, Igor Latorzeff, Etienne Martin, Valentine Guimas, Pascal Pommier, Thomas Leroy, Philippe Ronchin, Alexis Lepinoy, Audrey Grand, Lysian Cartier, Ossama Didas, Fabrice Denis, Vincent Libois, Audrey Blanc-Lapierre, Stéphane Supiot

    Get full text
    Article


  6. 6

    Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline by Nicolas Martz, Julia Salleron, Frédéric Dhermain, Guillaume Vogin, Jean-François Daisne, Raphaelle Mouttet-Audouard, Ronan Tanguy, Georges Noel, Matthieu Peyre, Isabelle Lecouillard, Julian Jacob, Justine Attal, Marie Charissoux, Ovidiu Veresezan, Chantal Hanzen, Aymeri Huchet, Igor Latorzeff, Alexandre Coutte, Jérôme Doyen, Dinu Stefan, Loic Feuvret, Gabriel C. T. E. Garcia, Philippe Royer

    Published in Radiation Oncology (2023-07-01)
    Get full text
    Article


Search Tools: